| UHS to Buy Psychiatric Solutions Universal Health Services agreed to acquire mental-health inpatient clinic operator Psychiatric Solutions for about $2 billion. Bain Capital had neared a deal two months ago. online.wsj.com |
Vivus: An Option Pricing Case Study Bill Luby submits: Trading in Vivus (VVUS) was halted this morning, as the biotechnology company’s new weight-loss pill, Qnexa, is being reviewed by a panel of experts at the FDA. In many respects biotechnology stocks – particularly those which do not yet have products that are commercially available – are options dressed up as stocks. More than other sectors, a biotechnology stock is a company that is a portfolio of options on all the projects (drugs) that are in the research and development stage, plus commercial products which can be valued with more traditional discounted cash flow models and the like.Complete Story » seekingalpha.com |
Cord Blood America Says U.S., Worldwide Research Shows Umbilical Cord Blood Stem Cells Could Be Crucial in Combating Difficult to Cure Diseases (PR Newswire) Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that clinical trials ongoing in the U.S. using umbilical cord blood in the treatment of cerebral palsy, high-risk hematologic cancer, injured spinal cords and Type 1 diabetes provide significant further evidence of the importance of storing umbilical cord blood at the time of birth. us.rd.yahoo.com |
Another Setback for Roche's Cancer Drug The Burrill Report submits: By Michael FitzhughAvastin, Roche's (RHHBY.PK) phenomenally successful advanced cancer medicine, did not help people with early-stage colon cancer live longer or reduce their risk of relapses when combined with chemotherapy, new study data shows. Complete Story » seekingalpha.com |
St. Jude to Buy AGA Medical St. Jude Medical agreed to acquire AGA Medical in a cash-and-stock deal valued at about $1.1 billion. online.wsj.com |